Pgiam/iStock through Getty Pictures
Deutsche Financial institution upgraded West Pharmaceutical Providers (NYSE:WST) to Purchase from Maintain on Friday, even after the contract drug producer witnessed a ~38% drop within the earlier session following a worse-than-expected outlook issued with its This fall 2024 financials.
DB analysts argued that
